Nitto Denko Corporation
2 clinical trials · Sponsor
◉ Watch Nitto Denko Corporation
| Record | Firm | Date |
|---|---|---|
| JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF (NCT03538301) | Nitto Denko Corporation | 2018-06-18 |
Track Nitto Denko Corporation automatically
Every clearance here is in the API, with alerts when new ones post.